On the other hand, it has been reported that miR-30a-5p is a potential biomarker for PD [60], targeting and suppressing BDNF expression in the prefrontal cortex [61], and a lower BDNF level is associated with greater cognitive impairments in PD patients [9]. This evidence concerns the gene BDNF and Parkinson disease.